CASI Pharmaceuticals (NASDAQ:CASI) Now Covered by Analysts at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report) in a research report issued on Saturday. The firm set a “hold” rating on the biotechnology company’s stock. CASI Pharmaceuticals Trading Down 3.5 % NASDAQ CASI opened at $2.50 on Friday. CASI Pharmaceuticals has a 12-month low of $2.05 […]
Stock analysts at StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report) in a research report issued on Saturday. The firm set a “hold” rating on the biotechnology company’s stock. CASI Pharmaceuticals Trading Down 3.5 % NASDAQ CASI opened at $2.50 on Friday. CASI Pharmaceuticals has a 12-month low of $2.05 […]
